📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-08 15:16
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
16 announcements match the current filters (relevance ≥ 5).
India Ratings Affirms Chemfab Alkalis at 'IND BBB+/Negative' on INR 170 Cr Bank Loans
India Ratings has affirmed Chemfab Alkalis' bank loan facilities worth INR 170 Cr at 'IND BBB+' while maintaining a Negative outlook. The negative stance is driven by slower-than-expected recovery in consolidated performance and prolonged weakness in the OPVC pipe segment due to low Jal Jeevan Mission demand. However, the rating notes nascent recovery with an OPVC order book of around INR 17 Cr as of end-September 2026 and operational cost savings of INR 15 Cr annually from a recently commissioned hybrid power project. The company also secured INR 55.5 Cr of incremental capex reimbursement borrowings in 1HFY27, bolstering liquidity.
Confidence: HIGH
What changedIndia Ratings reaffirmed the credit rating for INR 170 Cr bank facilities at 'IND BBB+/Negative/IND A2', retaining a Negative outlook due to sluggish OPVC performance.
Why it mattersWhile the Negative outlook signals persistent operational drag in OPVC pipes, recent term loan sanctions (INR 55.5 Cr) and power-efficiency savings (INR 15 Cr/year) provide near-term financial resilience.
Rated Bank Facilities: INR 1700 millionNew Capex Loans Sanctioned: INR 555 millionAnnual Hybrid Power Savings: around INR 150 millionPipe Order Book (End-Sep 2026): around INR 170 millionRated Facility vs TTM Revenue: ~59.4%
📅 Short termLiquidity remains adequate with INR 12-13 Cr in undrawn working capital lines and term loan disbursements, but credit profile stays sensitive to further OPVC recovery delays.
📈 Long termCompletion of electrolyser modernization and expanding into non-JJM pipes are crucial to restoring consolidated EBITDA margins and reversing the negative rating outlook.
⚠ Risk flags
- Prolonged underutilisation of OPVC capacity if Jal Jeevan Mission project disbursements face further delays
- Cyclical swings in caustic soda prices constraining Chlor-Alkali margins
Key Highlights
India Ratings affirmed bank loan facilities of INR 170 Cr at 'IND BBB+/Negative/IND A2'
Secured incremental capex reimbursement term loans of INR 55.5 Cr in 1HFY27 (INR 40 Cr drawn)
Commissioned hybrid power project in May 2026, delivering expected annual cost savings of INR 15 Cr
OPVC pipe order book stood at INR 17 Cr at end-September 2026 vs Q1FY27 pipe revenue of INR 5.75 Cr
Chemicals share surged to 92% (INR 67.4 Cr) in Q1FY27 revenue as pipe revenue plummeted to INR 5.7 Cr
👀 What to Watch
Track the execution of the INR 17 Cr pipe order book in upcoming quarters and monitor sustained EBITDA benefits from the modernized membrane electrolyser and hybrid power plant.
Chemfab Q1FY27: EBITDA Up 18.9% QoQ Despite 85% YoY Drop in OPVC Revenue
Chemfab Alkalis reported a consolidated revenue of ₹73.16 Cr for Q1FY27, a 20% YoY decline driven by a sharp 85% drop in OPVC segment revenue to ₹5.75 Cr due to Jal Jeevan Mission funding delays. Despite lower revenue, operational EBITDA grew 18.9% sequentially to ₹10.13 Cr, aided by improved ECU realizations of ₹39,600/MT in the Chlor-Alkali business. The company commenced its 10 MW Captive Hybrid Power plant on May 25, 2026, which is expected to structurally lower production costs. Management maintains a positive outlook with OPVC capacity expanding to 20,000 TPA by FY26.
Confidence: HIGH
What changedThe company has operationalized its captive hybrid power plant and received BIS approval for OPVC pipes in sewage applications, while facing a temporary but severe revenue contraction in its piping division.
Why it mattersThe shift to captive power reduces vulnerability to high energy costs in the Chlor-Alkali segment, while the OPVC expansion (targeting 20,000 TPA) represents the company's primary growth engine outside of commodity chemicals.
Q1FY27 Consolidated Revenue: ₹73.16 CrOPVC Revenue vs TTM Revenue: ~1.8%ECU Realisation: ₹39,600/MTOPVC Capacity Target (FY26): 20,000 TPAHybrid Power Capacity: 10 MWQoQ EBITDA Growth: 18.90%
📅 Short termThe stock may face pressure due to the significant YoY revenue decline, but the sequential improvement in profitability and management's guidance on JJM fund recovery provide a floor.
📈 Long termStructural cost reductions in Chlor-Alkali and the scaling of the high-margin OPVC business (41%+ margins) could re-rate the company if revenue targets of ₹500 Cr are achieved.
⚠ Risk flags
- High dependency on government infrastructure project funding (Jal Jeevan Mission)
- Volatility in global caustic soda prices impacting ECU realizations
- Energy-intensive production process sensitive to power costs
Key Highlights
Chlor-Alkali ECU realizations improved sequentially to ₹39,600 per MT from ₹39,100 in Q4FY26.
OPVC segment revenue plummeted 85.14% YoY to ₹5.75 Cr due to lack of fund flows under the Jal Jeevan Mission.
Commenced 10 MW Captive Hybrid Power supply on May 25, 2026, to drive long-term cost savings in energy-intensive operations.
OPVC segment maintained a high operational EBITDA margin of 41.57% despite the volume drop.
Consolidated Profit Before Tax (PBT) rose 80.49% QoQ to ₹2.22 Cr, though it remains down 52.77% YoY.
👀 What to Watch
Watch for the normalization of Jal Jeevan Mission fund releases in Q2FY27 and the resulting impact on OPVC order bookings in Q3FY27. Monitor if the 10 MW hybrid power plant leads to a sustained expansion in Chlor-Alkali margins.
Chemfab Q1 PAT Rises 125% to ₹5.73 Cr; MSKA & Associates Appointed as New Auditors
Chemfab Alkalis reported a 125% YoY increase in consolidated net profit to ₹5.73 Cr for Q1 FY27, despite a 20% decline in revenue to ₹73.16 Cr. The profit growth was significantly aided by a one-time deferred tax credit of ₹3.80 Cr as the company transitioned to a lower tax regime. Operationally, the Chemicals segment contributed ₹67.41 Cr in revenue, while the PVC-O Pipes segment saw a sharp decline to ₹5.75 Cr from ₹38.70 Cr YoY. The company also initiated a 5-year auditor rotation, appointing MSKA & Associates to replace Deloitte.
Confidence: HIGH
What changedThe company has transitioned to a lower tax regime and appointed MSKA & Associates as statutory auditors for a 5-year term following the expiry of Deloitte's tenure.
Why it mattersThe tax regime change improves long-term net margins, while the power plant investment addresses the high energy intensity of Chlor-Alkali production, which is a key margin driver.
Q1 FY27 Consolidated Revenue: ₹73.16 CrQ1 FY27 Consolidated PAT: ₹5.73 CrDeferred Tax Credit: ₹3.80 CrHybrid Power Investment: ₹14.91 CrInvestment vs Net Worth: ~3.6%
📅 Short termThe stock may see positive sentiment due to the bottom-line growth and tax efficiency, though the sharp revenue drop in the piping segment warrants caution.
📈 Long termStructural improvements in energy sourcing and tax efficiency are positive, but the company needs to demonstrate consistent growth in its high-margin OPVC segment to re-rate.
⚠ Risk flags
- Significant revenue volatility in the PVC-O segment
- Profitability for the quarter was heavily supported by a one-off tax credit
- High energy cost sensitivity
Key Highlights
Consolidated Net Profit increased 125% YoY to ₹5.73 Cr in Q1 FY27
Revenue from operations declined 20% YoY to ₹73.16 Cr from ₹91.54 Cr
Recognized a ₹3.80 Cr deferred tax credit following a shift to a lower tax rate regime
Invested ₹14.91 Cr in a hybrid power plant to optimize energy costs
PVC-O Pipes segment revenue dropped 85% YoY to ₹5.75 Cr
👀 What to Watch
Watch for the stabilization of the PVC-O pipe segment revenue and the impact of the ₹14.91 Cr hybrid power investment on operating margins in the next two quarters.
Chemfab Q1 Consolidated PAT Falls 81% to ₹0.48 Cr; ₹14.91 Cr Power Investment Approved
Chemfab Alkalis reported a weak Q1 FY27 with consolidated Net Profit dropping 81% YoY to ₹0.48 Cr from ₹2.55 Cr. While the core Chemicals segment revenue grew 27.6% YoY to ₹67.41 Cr, the PVC-O Pipes segment experienced a massive 85% revenue collapse, falling to ₹5.75 Cr from ₹38.70 Cr. Profitability was supported by a one-time deferred tax credit of ₹3.80 Cr; without this, the company would have likely reported a consolidated loss. To address high energy costs, the company invested ₹14.91 Cr (approx. 3.6% of net worth) in a hybrid power plant.
Confidence: HIGH
What changedThe company reported a significant decline in consolidated profitability and a major revenue shift away from its piping segment, alongside a new capital commitment for energy efficiency.
Why it mattersThe sharp drop in the piping segment revenue (down ₹32.95 Cr YoY) significantly impacts the company's growth profile, while the power investment is a strategic move to protect margins in its energy-sensitive chemical operations.
Consolidated Revenue (Q1 FY27): ₹73.16 CrConsolidated PAT (Q1 FY27): ₹0.48 CrPVC-O Pipes Revenue Change: -85% YoYHybrid Power Investment: ₹14.91 CrInvestment vs Net Worth: ~3.6%Deferred Tax Credit: ₹3.80 Cr
📅 Short termNegative sentiment is expected due to the sharp decline in consolidated profits and the volatility shown in the piping business.
📈 Long termThe long-term outlook depends on stabilizing the PVC-O segment and the successful integration of the Karaikal subsidiary's projects to reach the company's ₹500 Cr revenue target.
⚠ Risk flags
- Severe volatility in PVC-O Pipes segment revenue
- Consolidated profitability dependent on one-off tax credits
- High sensitivity to power costs in Chlor-Alkali production
Key Highlights
Consolidated Revenue from Operations declined 20% YoY to ₹73.16 Cr in Q1 FY27.
PVC-O Pipes segment revenue plummeted 85% YoY to ₹5.75 Cr from ₹38.70 Cr in the previous year.
Invested ₹14.91 Cr in a hybrid power plant to source power under a long-term agreement.
Consolidated Net Profit of ₹0.48 Cr was aided by a ₹3.80 Cr deferred tax credit following a shift to a lower tax regime.
Chemicals and Related Products segment revenue grew 27.6% YoY to ₹67.41 Cr.
👀 What to Watch
Investors should monitor the recovery of the PVC-O Pipes segment, which has historically been a high-margin driver but saw a severe contraction this quarter. Watch for the impact of the ₹14.91 Cr hybrid power investment on operating margins in the energy-intensive Chlor-Alkali business over the next 2-3 quarters.
Chemfab Q1 Net Profit Falls 81% YoY to ₹0.48 Cr; PVC-O Pipe Revenue Drops 85%
Chemfab Alkalis reported a weak Q1 FY27 with consolidated revenue declining 20% YoY to ₹73.16 Cr. The primary drag was the PVC-O Pipes segment, where revenue plummeted 85% YoY to ₹5.75 Cr from ₹38.70 Cr. Consolidated Net Profit fell 81% YoY to ₹0.48 Cr, a figure that was supported by a one-off deferred tax credit of ₹3.80 Cr following a shift to a lower tax regime. Operationally, the company invested ₹14.91 Cr in a hybrid power plant to mitigate high energy costs in its energy-intensive Chlor-Alkali business.
Confidence: HIGH
What changedThe company experienced a significant collapse in its piping business revenue while transitioning its statutory auditor from Deloitte to M S K A & Associates.
Why it mattersThe piping segment was intended to be a high-margin growth driver; its current weakness leaves the company heavily dependent on the volatile and energy-sensitive Chlor-Alkali chemicals business.
Consolidated Revenue (Q1): ₹73.16 CrYoY Revenue Growth: -20.1%PVC-O Segment Revenue: ₹5.75 CrDeferred Tax Credit: ₹3.80 CrPower Plant Investment: ₹14.91 CrInvestment vs Net Worth: ~3.6%
📅 Short termThe stock may face downward pressure due to the sharp decline in both top-line and bottom-line performance, especially given the reliance on a tax credit for profitability.
📈 Long termLong-term recovery depends on stabilizing the PVC-O pipe segment and achieving cost efficiencies through the new hybrid power sourcing agreement.
⚠ Risk flags
- Severe volatility in PVC-O pipe segment revenue
- High energy cost sensitivity
- Reliance on one-off tax adjustments for positive PAT
Key Highlights
Consolidated Revenue from Operations decreased 20.1% YoY to ₹73.16 Cr.
PVC-O Pipes segment revenue saw a sharp contraction of 85% YoY, falling to ₹5.75 Cr.
Net Profit dropped 81.2% YoY to ₹0.48 Cr, despite a ₹3.80 Cr deferred tax credit.
Invested ₹14.91 Cr in a hybrid power plant, representing ~3.6% of Net Worth.
Chemicals segment provided a partial hedge, with revenue growing 27.6% YoY to ₹67.41 Cr.
👀 What to Watch
Investors should monitor the recovery of the PVC-O piping segment, which is critical for margins, and observe if the ₹14.91 Cr power investment successfully reduces energy costs in upcoming quarters.
Chemfab Alkalis Invests ₹14.91 Cr in Zenataris Renewable for 3.35% Stake
Chemfab Alkalis Limited has invested approximately ₹14.91 crore to acquire a 3.35% equity stake in Zenataris Renewable Energy Private Limited. This strategic investment is structured under a group captive power mechanism to secure renewable energy for the company's operations. The primary objective is to benefit from lower power tariffs, which is expected to lead to significant operational cost savings. Zenataris is an established player in the renewable sector, managing a portfolio of solar and wind power assets since 2018.
Key Highlights
Total investment of ₹14,90,99,985.30 for a 3.35% equity stake.
Shares were acquired at a price of ₹66.10 per share via cash consideration.
Investment is aimed at securing renewable power under a group captive mechanism to reduce energy costs.
Zenataris Renewable Energy specializes in developing and managing solar and wind power portfolios.
👀 What to Watch
Investors should view this as a margin-accretive move that addresses high energy costs in the alkali business. Monitor future quarterly results to see the actual impact of lower power tariffs on the company's operating margins.
Chemfab Alkalis Q4 FY26: EBITDA Rises 61.7% QoQ; OPVC Capacity Reaches 20,000 TPA
Chemfab Alkalis reported a sequential recovery in Q4 FY26, with consolidated revenue growing 10.57% QoQ to ₹68.74 Cr and EBITDA jumping 61.7% QoQ to ₹8.36 Cr. The Chlor-Alkali segment saw ECU realizations improve to ₹39,100 per MT, while the OPVC segment maintained high margins of 23.57% despite temporary demand headwinds. Management expects a materially stronger FY27 driven by the completion of its modernization program, the imminent start of a hybrid power plant in May 2026, and the revival of Jal Jeevan Mission 2.0 funding.
Key Highlights
Consolidated EBITDA margin expanded by 385 bps QoQ to 12.16% in Q4 FY26.
OPVC capacity expanded to 20,000 TPA following the commissioning of Lines 5 and 6.
ECU realizations in the Chlor-Alkali segment improved sequentially from ₹38,500 to ₹39,100 per MT.
Captive Hybrid Power Plant expected to commence supply in late May 2026, targeting 45% renewable power sourcing.
Management anticipates significant volume and profitability growth in FY27 due to cost efficiencies and demand revival.
👀 What to Watch
Investors should look for the realization of cost savings from the hybrid power plant and the recovery of OPVC volumes in Q2 FY27. The company's successful capacity expansion and modernization position it well for a cyclical upturn.
Chemfab Alkalis Recommends ₹1.25 Final Dividend for FY 2025-26
Chemfab Alkalis Limited has recommended a final dividend of ₹1.25 per equity share for the financial year ended March 31, 2026, pending shareholder approval. While the company announced this payout, the auditor's report highlights that the group recorded a consolidated net loss for the full fiscal year. The board also approved the appointment of M/s. Brahmayya & Co as Internal Auditors and reappointed M/s. Madhavan, Mohan & Associates as Cost Auditors for the upcoming 2026-27 fiscal year. The statutory auditors issued an unmodified opinion on the financial results, confirming their accuracy despite the reported losses.
Key Highlights
Recommended a final dividend of ₹1.25 per equity share for the financial year 2025-26.
Reported a consolidated net loss and consolidated other comprehensive loss for the year ended March 31, 2026.
Appointed M/s. Brahmayya & Co, Chartered Accountants, as Internal Auditors for FY 2026-27.
Statutory auditors Deloitte Haskins & Sells LLP provided an unmodified opinion on the annual financial statements.
Incorporated a new subsidiary, Chemfab Hiitech Piping Limited, on October 28, 2025.
👀 What to Watch
Investors should weigh the dividend yield against the reported consolidated net loss to determine the sustainability of future payouts. It is advisable to review the full earnings report to understand the specific factors driving the consolidated loss despite the dividend recommendation.
Chemfab Alkalis Recommends ₹1.25 Dividend; Reports Consolidated Net Loss for FY26
Chemfab Alkalis has recommended a final dividend of ₹1.25 per equity share for the financial year ended March 31, 2026. While the company maintained standalone profitability, the consolidated financial results for the full year reported a net loss, suggesting performance drag from subsidiaries. The board also approved the appointment of M/s. Brahmayya & Co as Internal Auditors for FY 2026-27. Additionally, the company integrated its new subsidiary, Chemfab Hiitech Piping Limited, which was incorporated in October 2025.
Key Highlights
Recommended a final dividend of ₹1.25 per equity share for the financial year 2025-26.
Reported a consolidated net loss and consolidated other comprehensive loss for the year ended March 31, 2026.
Appointed M/s. Brahmayya & Co, a 90-year-old firm, as Internal Auditors for the 2026-27 fiscal year.
Standalone financial results for FY26 remained profitable with an unmodified audit opinion.
Consolidated results now include Chemfab Hiitech Piping Limited, incorporated on October 28, 2025.
👀 What to Watch
Investors should investigate the specific factors causing the consolidated net loss despite standalone profits, particularly the performance of new subsidiaries. Monitor the impact of the newly incorporated piping division on future cash flows.
Chemfab Alkalis FY26 Results: ₹1.25 Dividend Declared, New Internal Auditors Appointed
Chemfab Alkalis has approved its audited financial results for the fiscal year ending March 31, 2026, and recommended a final dividend of ₹1.25 per share. Notably, the auditor's report indicates a consolidated net loss for the full financial year, despite the dividend recommendation. The company has also appointed M/s. Brahmayya & Co as Internal Auditors and reappointed M/s. Madhavan, Mohan & Associates as Cost Auditors for the 2026-27 fiscal year. Additionally, the consolidated results now include the newly incorporated subsidiary, Chemfab Hiitech Piping Limited.
Key Highlights
Board recommended a final dividend of ₹1.25 per equity share for FY 2025-26.
M/s. Brahmayya & Co appointed as Internal Auditors for a one-year term starting April 1, 2026.
Auditor's report highlights a consolidated net loss and consolidated other comprehensive loss for FY26.
The company incorporated a new subsidiary, Chemfab Hiitech Piping Limited, on October 28, 2025.
Statutory auditors (Deloitte) issued an unmodified opinion on the standalone financial results.
👀 What to Watch
Investors should investigate the cause of the consolidated net loss, particularly the performance of new subsidiaries, while weighing the ₹1.25 dividend yield. Monitor the upcoming Annual General Meeting for further management commentary on the path to consolidated profitability.
Chemfab Alkalis FY26 Results: Recommends ₹1.25 Dividend Amid Consolidated Net Loss
Chemfab Alkalis Limited has approved its audited financial results for the year ended March 31, 2026, recommending a final dividend of ₹1.25 per share. Despite the dividend payout, the statutory auditor's report highlights that the group recorded a consolidated net loss for the fiscal year. The company also announced the appointment of M/s. Brahmayya & Co as internal auditors and noted the inclusion of a new subsidiary, Chemfab Hiitech Piping Limited, incorporated in October 2025. The standalone results received an unmodified opinion, indicating financial reporting integrity despite the loss.
Key Highlights
Recommended a final dividend of ₹1.25 per equity share for the financial year 2025-26.
Reported a consolidated net loss and consolidated other comprehensive loss for the year ended March 31, 2026.
Appointed M/s. Brahmayya & Co as Internal Auditors for the 2026-2027 financial year.
Incorporated a new subsidiary, Chemfab Hiitech Piping Limited, on October 28, 2025.
Statutory auditors issued an unmodified opinion on the standalone financial results.
👀 What to Watch
Investors should investigate the drivers behind the consolidated net loss and assess if the new piping subsidiary is contributing to higher initial costs. While the dividend provides a minor yield, the shift to a consolidated loss warrants a cautious approach until operational efficiency improves.
India Ratings Downgrades Chemfab Alkalis to 'IND BBB+'; Outlook Negative
India Ratings and Research has downgraded Chemfab Alkalis Limited's long-term rating from 'IND A-' to 'IND BBB+' with a Negative outlook. The downgrade is driven by a 38% YoY decline in 9MFY26 EBITDA to INR 187 million and a sharp rise in net leverage to 3.6x from 1.4x in FY25. Liquidity has become severely stretched, with cash balances falling to nearly zero (INR 0.3 million) following heavy capex of INR 3,400 million since FY23. The company is struggling with low caustic soda prices and sluggish demand in its pipe business due to delays in the Jal Jeevan Mission.
Key Highlights
Long-term credit rating downgraded to 'IND BBB+' from 'IND A-' with a Negative outlook.
Net leverage (Net Debt/EBITDA) surged to 3.6x in 9MFY26 from 1.4x in FY25.
9MFY26 EBITDA fell 38% YoY to INR 187 million due to weak caustic soda realizations.
Cash and liquid investments plummeted to INR 0.3 million from INR 210 million in FY25.
Interest coverage ratio deteriorated to 3.4x in 9MFY26 from 8.9x in FY25.
👀 What to Watch
Investors should remain cautious as the rating downgrade and negative outlook signal heightened financial risk and liquidity pressure. Key monitorables include the recovery of caustic soda prices and the successful ramp-up of the new OPVC pipe capacity to improve cash flows.
Chemfab Alkalis Reports Q3 Net Loss of ₹1.04 Cr as Revenue Drops 22% YoY
Chemfab Alkalis Limited reported a weak performance for the quarter ended December 31, 2025, swinging to a standalone net loss of ₹1.04 crore from a profit of ₹4.02 crore in the previous year's corresponding quarter. Total revenue from operations declined by 21.9% YoY to ₹61.85 crore, primarily due to a significant 57.5% slump in the PVC-O Pipes segment. While the Chemicals segment saw a marginal revenue growth of 6.2%, it continued to operate at a segment loss of ₹1.94 crore. The company's profitability was further pressured by rising finance costs and a sharp decline in segment results from the piping division.
Key Highlights
Standalone Revenue from Operations fell 21.9% YoY to ₹61.85 crore from ₹79.21 crore.
Reported a Standalone Net Loss of ₹1.04 crore compared to a Net Profit of ₹4.02 crore in Q3 FY25.
PVC-O Pipes segment revenue plummeted to ₹14.65 crore from ₹34.46 crore in the same quarter last year.
Chemicals segment revenue stood at ₹47.52 crore, showing a slight recovery from ₹44.75 crore YoY.
Finance costs increased by 21.3% YoY to ₹1.97 crore, impacting the bottom line.
👀 What to Watch
Investors should exercise caution as the company has turned loss-making due to a severe downturn in the PVC-O Pipes segment. It is advisable to wait for signs of margin recovery in the Chemicals business and stabilization in the piping division before considering new positions.
Chemfab Alkalis Q3 FY26: Revenue Drops 21% YoY to ₹62.17 Cr; Reports PBT Loss of ₹1.38 Cr
Chemfab Alkalis reported a weak Q3 FY26 performance with consolidated revenue declining 21.5% YoY to ₹62.17 Cr and a PBT loss of ₹1.38 Cr compared to a profit of ₹5.76 Cr in the previous year. The Chlor Alkali segment faced soft global pricing, though ECU realisations showed sequential improvement to ₹38,500 per MT. The OPVC segment was significantly impacted by funding delays in the Jal Jeevan Mission, leading to a 57.5% YoY revenue drop in that division. Management remains optimistic about a recovery in Q4 FY26 following the completion of a technology modernization program and the expected start of captive hybrid power supply.
Key Highlights
Consolidated EBITDA slumped 64.32% YoY to ₹5.17 Cr with margins contracting to 8.32% from 18.29% YoY.
Chlor Alkali segment revenue grew 6.19% YoY to ₹47.52 Cr, but EBITDA margin remained low at 3.72%.
OPVC segment revenue fell sharply by 57.49% YoY to ₹14.65 Cr due to slow fund flows in government infrastructure projects.
Technology Modernisation Programme successfully completed with the new plant commissioned on December 30, 2025.
Captive Hybrid Power Plant is awaiting final clearances and is expected to drive cost savings starting Q4 FY26.
👀 What to Watch
Investors should watch for the operational stabilization of the newly modernized plant and the impact of hybrid power on margins in the next quarter. While current results are poor, the sequential improvement in ECU realisations and non-JJM business growth in OPVC suggest a potential bottoming out.
Chemfab Alkalis Reports Q3 FY26 Net Loss of ₹1.04 Cr as Revenue Declines 22% YoY
Chemfab Alkalis reported a weak performance for Q3 FY26, swinging to a standalone net loss of ₹103.80 lakhs compared to a profit of ₹401.76 lakhs in the same quarter last year. Revenue from operations fell significantly to ₹6,185.38 lakhs, down 21.9% year-on-year, primarily due to lower contributions from the PVC-O Pipes segment. The Chemicals segment also struggled, reporting a loss at the EBIT level of ₹193.60 lakhs. Despite the downturn, the company expanded its corporate structure by incorporating a new subsidiary, Chemfab Hiitech Piping Limited, in October 2025.
Key Highlights
Revenue from operations dropped 21.9% YoY to ₹6,185.38 lakhs from ₹7,920.54 lakhs.
Reported a standalone net loss of ₹103.80 lakhs against a profit of ₹401.76 lakhs in Q3 FY25.
PVC-O Pipes segment revenue saw a sharp decline to ₹1,464.95 lakhs from ₹3,446.02 lakhs YoY.
Chemicals segment recorded a loss of ₹193.60 lakhs at the segment result level.
Incorporated a new subsidiary, Chemfab Hiitech Piping Limited, on October 28, 2025.
👀 What to Watch
Investors should be cautious as the company has turned loss-making this quarter with significant pressure on both top-line and margins. Monitor the recovery in the PVC-O Pipes segment and the performance of the newly formed subsidiary for signs of a turnaround.
Chemfab Alkalis Commissions New INEOS Electrolyser with Rs 57 Cr Investment
Chemfab Alkalis has successfully commissioned a latest-generation INEOS Electrolyser, replacing its 30-year-old 2nd-Generation UHDE unit. The project involved a capital expenditure of approximately Rs 57 crores, which was entirely funded through internal accruals. While the production capacity remains unchanged at 180 tonnes per day, the upgrade is designed to significantly improve operational efficiency and reliability. The company expects to realize power savings and cost optimization starting from Q4 of the Financial Year 2025-26.
Key Highlights
Replacement of 30-year-old legacy equipment with latest generation INEOS Electrolyser
Total project investment of approximately Rs 57 crores funded via internal accruals
Maintains existing consent capacity of 180 tonnes per day with enhanced reliability
Anticipated power savings and cost optimization starting from Q4 FY 2025-26
👀 What to Watch
Investors should monitor the company's operating margins in the coming quarters to verify the impact of expected power savings. The funding of this modernization through internal accruals reflects a strong cash position and disciplined capital allocation.
